DV
Dividend Vision

WGS — GeneDx Holdings Corp.

GeneDx Holdings Corp. (WGS)

Total return is -75.9% over the past 5.8 years, 220.3 points behind SPY at 144.4%. Its deepest 1-year drawdown was 79.4%.

WGS is an equity fund that holds GeneDx Holdings Corp. stock, a healthcare company operating in genetic diagnostics. The fund does not currently pay distributions and lacks published expense ratio and asset information. This holding appeals primarily to growth-oriented investors seeking exposure to the genomic medicine sector rather than income-focused dividend investors.

WGS key facts

Asset type
Stock
Asset class
Equity
Inception date
11/04/2020
Distribution frequency
None
Last close
$78.08
Market cap
$2,328,544,000
Average volume
391800.0
Beta
1.975
Payout ratio
0.0
Forward P/E
243.9024
EPS
$-3.63